Combination of direct rennin inhibitor - aliskiren, angiotensin II receptor blocker - valsartan, and calcium channel blocker - amlodipine, in therapy of hypertensive patient with gout (case report)

被引：0

作者：

Dralova, O. V. ^{[1
]}

Maksimov, M. L. ^{[1
]}

机构：

[1] IM Setchenov First Moscow State Med Univ, Trubetskaya Ul 8-2, Moscow 119991, Russia

来源：

RATIONAL PHARMACOTHERAPY IN CARDIOLOGY | 2011年 / 7卷 / 04期

关键词：

arterial hypertension; gout; valsartan; amlodipine; aliskiren;

D O I：

10.20996/1819-6446-2011-7-4-468-472

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Pharmacotherapy optimization in patients with arterial hypertension and gout is very important. Achievement of the target blood pressure levels is possible with the use of combinations of effective antihypertensive drugs with neutral metabolic profile and safety, in particular a combination of valsartan, amlodipine and aliskiren. Clinical case of this combination use in patient with arterial hypertension and gout is presented.

引用

页码：468 / 472

页数：5

共 14 条

[1] GOUT AND CORONARY HEART-DISEASE - THE FRAMINGHAM-STUDY [J].

ABBOTT, RD ;

BRAND, FN ;

KANNEL, WB ;

CASTELLI, WP .

JOURNAL OF CLINICAL EPIDEMIOLOGY, 1988, 41 (03) :237-242

[2]

Chazova IE, 2010, SISTEMNYE GIPERTENZI, V4, P14

[3]

CHAZOVA IE, 2011, KARDIOLOGICHESKIY VE, V6, P40

[4] Prevalence of the metabolic syndrome in patients with gout: The Third National Health and Nutrition Examination Survey [J].

Choi, Hyon K. ;

Ford, Earl S. ;

Li, Chaoyang ;

Curhan, Gary .

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2007, 57 (01) :109-115

[5]

Eliseev MS, 2006, ANN RHEUM DIS, V65, P432

[6] The impact of serum uric acid on cardiovascular outcomes in the LIFE study [J].

Hoieggen, A ;

Alderman, MH ;

Kjeldsen, SE ;

Julius, S ;

Devereux, RB ;

de Faire, U ;

Fyhrquist, F ;

Ibsen, H ;

Kristianson, K ;

Lederballe-Pedersen, O ;

Lindholm, LH ;

Nieminen, MS ;

Omvik, P ;

Oparil, S ;

Wedel, H ;

Chen, C ;

Dahlöf, B .

KIDNEY INTERNATIONAL, 2004, 65 (03) :1041-1049

[7] Direct renin inhibition with aliskiren in obese patients with arterial hypertension [J].

Jordan, Jens ;

Engeli, Stefan ;

Boye, Sam W. ;

Le Breton, Stephanie ;

Keefe, Deborah L. .

HYPERTENSION, 2007, 49 (05) :1047-1055

[8]

Kobalava Zh.D., 2003, KLINICHESKAYA FARM 1, V12, P15

[9]

Mychka V. B., 2010, SISTEMNYE GIPERTENZI, V3, P71

[10] Uric acid and the state of the intrarenal renin-angiotensin system in humans [J].

Perlstein, TS ;

Gumieniak, O ;

Hopkins, PN ;

Murphey, LJ ;

Brown, NJ ;

Williams, GH ;

Hollenberg, NK ;

Fisher, NDL .

KIDNEY INTERNATIONAL, 2004, 66 (04) :1465-1470

← 1 2 →